Aktuelle Neurologie 2013; 40(09): 478-485
DOI: 10.1055/s-0033-1357177
Neues in der Neurologie
© Georg Thieme Verlag KG Stuttgart · New York

Neues aus der Forschung zum Komplexen Regionalen Schmerzsyndrom (CRPS)

Recent Research on Complex Regional Pain Syndrome (CRPS)
E. Krumova
1   Neurologische Klinik und Poliklinik, BG-Universitätsklinikum Bergmannsheil, Ruhr-Universität, Bochum
,
C. Maier
2   Abteilung für Schmerzmedizin, BG-Universitätsklinikum Bergmannsheil, Ruhr-Universität, Bochum
,
M. Tegenthoff
1   Neurologische Klinik und Poliklinik, BG-Universitätsklinikum Bergmannsheil, Ruhr-Universität, Bochum
› Author Affiliations
Further Information

Publication History

Publication Date:
15 October 2013 (online)

Zusammenfassung

Das komplexe regionale Schmerzsyndrom (complex regional pain syndrome; CRPS) entwickelt sich typischerweise nach Extremitätenverletzungen, manifestiert sich generalisiert im distalen Bereich einer Extremität und ist durch Störungen der Sensorik und Motorik, der Vaso- und Sudomotorik, der Trophik und durch Gelenkveränderungen charakterisiert. Die Fälle ohne Nervenläsion werden als Typ I bezeichnet, diejenigen mit einer Nervenläsion – als Typ II. Die Diagnosestellung erfolgt primär aufgrund des klinischen Bildes anhand der aktuellen sog. Budapest-Kriterien. Bedeutsam für die Diagnose ist neben definierten klinischen Parametern der weitreichende Ausschluss anderweitiger Ursachen für die anamnestisch berichteten Symptome und die nachweisbare klinische Symptomatik. Für die Früh- und Differenzialdiagnose ist die Dreiphasenskelettszintigrafie hilfreich, da diese eine hohe Spezifität (98%) aufweist, während die Sensitivität im Verlauf der Erkrankung abnimmt. Im Akutstadium der Erkrankung scheinen proinflammatorische Faktoren primär an der Pathogenese beteiligt zu sein, sodass sich ein möglicher Therapieansatz ergeben kann. Im Verlauf nimmt ihre Bedeutung unabhängig vom klinischen Schweregrad ab. Chronische Stadien werden vor allem durch zentralnervöse Veränderungen mit Verminderung der kortikalen Repräsentation der betroffenen Extremität, Störungen des Körperschemas, Neglect-ähnlichen Symptomen sowie dystone Fehlstellungen bestimmt. Das häufigste pathologische sensorische Symptom ist die Druckhyperalgesie über der Muskulatur, erklärbar vermutlich als Folge einer überwiegend peripheren Sensibilisierung. Zusätzlich zu den klinisch nachweisbaren fokalen autonomen Störungen finden sich beim CRPS auch generalisierte Störungen autonomer Funktionen. Dystone Symptome sind hinsichtlich ihrer Pathogenese weiterhin schlecht verstanden und somit häufig schwer therapeutisch erreichbar. Die Therapie des CRPS sollte multimodal im interdisziplinären Setting erfolgen, angepasst an das Schmerzniveau. Invasive Maßnahmen sollten spezialisierten Zentren unter strenger Indikationsstellung überlassen werden.

Abstract

Complex regional pain syndrome (CRPS) typically develops following extremity injuries and is characterised by distally generalised sensory, motor, trophic, vaso- and sudomotor dysfunctions, as well as joint affliction. CRPS cases with­out nerve lesions are defined as type I – those involving nerve damage as type II. The diagnosis is primarily based on the clinical presentation using the so called ‘Budapest criteria’. Important for the diagnosis is the exclusion of other potential conditions which could account for the pa­tient-reported symptoms and demonstrable clinical signs. Triple-phase bone scans are helpful for the early and differential diagnosis due to their high specificity (98%), although their sensitivity decreases as the disease progresses. In the acute stage of the disease, pro-inflammatory factors seem to play an important role, allowing for a potential therapeutic approach. As the disease progresses, however, they are unrelated to the clinical severity. Chronic stages are primarily determined by central nervous system changes including a reduced cortical representation of the affected limb, changes in body scheme, neglect-like symptoms, as well as dystonic deformities. The most common sensory abnormality is pressure hyperalgesia over muscles, most likely a result of peripheral sensitisation. In addition to the clinically detectable focal autonomic disorders, more generalised autonomic dysfunction is also found. The pathogenesis of dystonic symptoms, however, remains poorly understood, making therapeutic treatment more difficult. Treatment of CRPS should be multimodal and take place in a multi-disciplinary setting, adapted to the level of pain. Invasive interventions should be limited to strict indications and specialised centres.

 
  • Literatur

  • 1 Harden RN, Oaklander AL, Burton AW et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med 2013; 14: 180-229
  • 2 Krumova EK, Frettlöh J, Klauenberg S et al. Long-term skin temperature measurements – a practical diagnostic tool in complex regional pain syndrome. Pain 2008; 140: 8-22
  • 3 Pepper A, Li W, Kingery WS et al. Changes resembling complex regional pain syndrome following surgery and immobilization. J Pain 2013; 14: 516-524
  • 4 Ringer R, Wertli M, Bachmann LM et al. Concordance of qualitative bone scintigraphy results with presence of clinical complex regional pain syndrome 1: meta-analysis of test accuracy studies. Eur J Pain 2012; 16: 1347-1356
  • 5 Cappello ZJ, Kasdan ML, Louis DS. Meta-analysis of imaging techniques for the diagnosis of complex regional pain syndrome type I. J Hand Surg Am 2012; 37: 288-296
  • 6 Wüppenhorst N, Maier C, Frettlöh J et al. Sensitivity and specificity of 3-phase bone scintigraphy in the diagnosis of complex regional pain syndrome of the upper extremity. Clin J Pain 2010; 26: 182-189
  • 7 Gierthmühlen J, Maier C, Baron R et al. German Research Network on Neuropathic Pain (DFNS) study group. Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain 2012; 153: 765-774
  • 8 Oaklander AL, Rissmiller JG, Gelman LB et al. Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy). Pain 2006; 120: 235-243
  • 9 Kharkar S, Venkatesh YS, Grothusen JR et al. Skin biopsy in complex regional pain syndrome: case series and literature review. Pain Physician 2012; 15: 255-266
  • 10 van Rooijen DE, Marinus J, Schouten AC et al. Muscle hyperalgesia correlates with motor function in complex regional pain syndrome type 1. J Pain 2013; 14: 446-454
  • 11 Maihöfner C, Handwerker HO, Neundörfer B et al. Cortical reorganiza­tion during recovery from complex regional pain syndrome. Neurology 2004; 63: 693-701
  • 12 Pleger B, Ragert P, Schwenkreis P et al. Patterns of cortical reorganization parallel impaired tactile discrimination and pain intensity in complex regional pain syndrome. Neuroimage 2006; 32: 503-510
  • 13 Pleger B, Tegenthoff M, Ragert P et al. Sensorimotor retuning in complex regional pain syndrome parallels pain reduction. Ann Neurol 2005; 57: 425-429
  • 14 Di Pietro F, McAuley JH, Parkitny L et al. Primary Somatosensory Cortex Function in Complex Regional Pain Syndrome: A Systematic Review and Meta-Analysis. J Pain 2013; pii S1526-5900(13)00937-1
  • 15 Lenz M, Höffken O, Stude P et al. Bilateral somatosensory cortex disinhibition in complex regional pain syndrome type I. Neurology 2011; 77: 1096-1101
  • 16 Reiswich J, Krumova EK, David M et al. Intact 2D-form recognition despite impaired tactile spatial acuity in complex regional pain syndrome type I. Pain 2012; 153: 1484-1494
  • 17 Legrain V, Bultitude JH, De Paepe AL et al. Pain, body, and space: what do patients with complex regional pain syndrome really neglect?. Pain 2012; 153: 948-951
  • 18 Punt TD, Cooper L, Hey M et al. Neglect-like symptoms in complex regional pain syndrome: learned nonuse by another name?. Pain 2013; 154: 200-203
  • 19 Kolb L, Lang C, Seifert F et al. Cognitive correlates of “neglect-like syndrome” in patients with complex regional pain syndrome. Pain 2012; 153: 1063-1073
  • 20 Peltz E, Seifert F, Lanz S et al. Impaired hand size estimation in CRPS. J Pain 2011; 12: 1095-1101
  • 21 Lewis JS, Schweinhardt P. Perceptions of the painful body: the relationship between body perception disturbance, pain and tactile discrimination in complex regional pain syndrome. Eur J Pain 2012; 16: 1320-1330
  • 22 Reinersmann A, Haarmeyer GS, Blankenburg M et al. Left is where the L is right. Significantly delayed reaction time in limb laterality recognition in both CRPS and phantom limb pain patients. Neurosci Lett 2010; 486: 240-245
  • 23 Reinersmann A, Landwehrt J, Krumova EK et al. Impaired spatial body representation in complex regional pain syndrome type 1 (CRPS I). Pain 2012; 153: 2174-2181
  • 24 Reinersmann A, Landwehrt J, Krumova EK et al. The rubber hand illu­sion in complex regional pain syndrome: Preserved ability to integrate a rubber hand indicates intact multisensory integration. Pain 2013; pii S0304-3959(13)00153-X
  • 25 Mutso AA, Radzicki D, Baliki MN et al. Abnormalities in hippocampal functioning with persistent pain. J Neurosci 2012; 32: 5747-5756
  • 26 Schilder JC, Schouten AC, Perez RS et al. Motor control in complex regional pain syndrome: a kinematic analysis. Pain 2012; 153: 805-812
  • 27 Huge V, Lauchart M, Förderreuther S et al. Interaction of hyperalgesia and sensory loss in complex regional pain syndrome type I (CRPS I). PLoS One 2008; 3: e2742
  • 28 Bank PJ, Peper CL, Marinus J et al. Deficient muscle activation in patients with Complex Regional Pain Syndrome and abnormal hand postures: An electromyographic evaluation. Clin Neurophysiol 2013; pii S1388-2457(13)00310-6
  • 29 Mugge W, Schouten AC, Bast GJ et al. Stretch reflex responses in Complex Regional Pain Syndrome-related dystonia are not characterized by hyperreflexia. Clin Neurophysiol 2012; 123: 569-576
  • 30 Mugge W, van der Helm FCT, Schouten AC. Integration of Sensory Force Feedback Is Disturbed in CRPS-Related Dystonia. PLoS ONE 8: e60293
  • 31 Linnman C, Becerra L, Lebel A et al. Transient and persistent pain induced connectivity alterations in pediatric complex regional pain syndrome. PLoS One 2013; 8 : e57205
  • 32 van Rooijen DE, Roelen DL, Verduijn W et al. Genetic HLA associations in complex regional pain syndrome with and without dystonia. J Pain 2012; 13: 784-789
  • 33 Wasner G, Schattschneider J, Heckmann K et al. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain 2001; 124: 587-599
  • 34 Cohen HE, Hall J, Harris N et al. Enhanced pain and autonomic responses to ambiguous visual stimuli in chronic Complex Regional Pain Syndrome (CRPS) type I. Eur J Pain 2012; 16: 182-195
  • 35 Terkelsen AJ, Gierthmühlen J, Petersen LJ et al. Cutaneous noradrenaline measured by microdialysis in complex regional pain syndrome during whole-body cooling and heating. Exp Neurol 2013; pii S0014-4886(13)00030-7
  • 36 Terkelsen AJ, Mølgaard H, Hansen J et al. Heart rate variability in complex regional pain syndrome during rest and mental and orthostatic stress. Anesthesiology 2012; 116: 133-146
  • 37 Park JY, Ahn RS. Hypothalamic-pituitary-adrenal axis function in patients with complex regional pain syndrome type 1. Psychoneuroendocrinology 2012; 37: 1557-1568
  • 38 Taha R, Blaise GA. Update on the pathogenesis of complex regional pain syndrome: role of oxidative stress. Can J Anaesth 2012; 59: 875-881
  • 39 Parkitny L, McAuley JH, Di Pietro F et al. Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology 2013; 80: 106-117
  • 40 Alexander GM, Peterlin BL, Perreault MJ et al. Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome. J Pain 2012; 13: 10-20
  • 41 Lenz M, Üçeyler N, Frettlöh J et al. Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain 2013. Epub ahead of print
  • 42 Derenthal N, Maecken T, Krumova E et al. Morphological macrovascular alterations in complex regional pain syndrome type I demonstrated by increased intima-media thickness. BMC Neurol 2013; 13: 14
  • 43 Fischer SG, Perez RS, Nouta J et al. Oxidative Stress in Complex Regional Pain Syndrome (CRPS): No Systemically Elevated Levels of Malondialdehyde, F2-Isoprostanes and 8OHdG in a Selected Sample of Patients. Int J Mol Sci 2013; 14: 7784-7794
  • 44 Oki G, Wada T, Iba K et al. Metallothionein deficiency in the injured peripheral nerves of complex regional pain syndrome as revealed by proteomics. Pain 2012; 153: 532-539
  • 45 Dirckx M, Groeneweg G, van Daele PL et al. Mast Cells: A New Target in the Treatment of Complex Regional Pain Syndrome?. Pain Pract 2013;
  • 46 Schlereth T, Birklein F. Mast cells: source of inflammation in complex regional pain syndrome?. Anesthesiology 2012; 116: 756-757
  • 47 Kwun BS, Park JW, Lee HJ et al. Complex regional pain syndrome by vaccination: a case of complex regional pain syndrome after vaccination of influenza A(H1N1). Pediatr Int 2012; 54: e4-e6
  • 48 Richards S, Chalkiadis G, Lakshman R et al. Complex regional pain syndrome following immunisation. Arch Dis Child 2012; 97: 913-915
  • 49 Kohr D, Singh P, Tschernatsch M et al. Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain 2011; 152: 2690-2700
  • 50 Goebel A, Blaes F. Complex regional pain syndrome, prototype of a novel kind of autoimmune disease. Autoimmun Rev 2013; 12: 682-686
  • 51 Cooper MS, Clark VP. Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome. J Neuroimmune Pharmacol 2013; 8: 452-469
  • 52 Dirckx M, Groeneweg G, Wesseldijk F et al. Report of a Preliminary Discontinued Double-Blind, Randomized, Placebo-Controlled Trial of the Anti-TNF-α Chimeric Monoclonal Antibody Infliximab in Complex Regional Pain Syndrome. Pain Pract 2013;
  • 53 Miclescu AA, Nordquist L, Hysing EB et al. Targeting Oxidative Injury and Cytokines’ Activity in the Treatment with Anti-Tumor Necrosis Factor-α Antibody for Complex Regional Pain Syndrome 1. Pain Pract 2013;
  • 54 Eisenberg E, Sandler I, Treister R et al. Anti tumor Necrosis Factor – Alpha Adalimumab for Complex Regional Pain Syndrome Type 1 (CRPS-I): A Case Series. Pain Pract 2013;
  • 55 Dirckx M, Stronks DL, Groeneweg G et al. Effect of immunomodulating medications in complex regional pain syndrome: a systematic review. Clin J Pain 2012; 28: 355-363
  • 56 Birthi P, Sloan P, Salles S. Subcutaneous botulinum toxin A for the treatment of refractory complex regional pain syndrome. PM R 2012; 4: 446-449
  • 57 van der Plas AA, van Rijn MA, Marinus J et al. Efficacy of intrathecal baclofen on different pain qualities in complex regional pain syndrome. Anesth Analg 2013; 116: 211-215
  • 58 Pickering AE, McCabe CS. Prolonged ketamine infusion as a therapy for Complex Regional Pain Syndrome: Synergism with antagonism?. Br J Clin Pharmacol 2013;
  • 59 Chopra P, Cooper MS. Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN). J Neuroimmune Pharmacol 2013; 8: 470-476
  • 60 Girtler R, Kloimstein H, Gustorff B. Pronounced symptom deterioration in complex regional pain syndrome type II after isolated application of a highly concentrated capsaicin patch. A case report. Schmerz 2013; 27: 67-71
  • 61 Kastler A, Aubry S, Sailley N et al. CT-guided stellate ganglion blockade vs. radiofrequency neurolysis in the management of refractory type I complex regional pain syndrome of the upper limb. Eur Radiol 2013; 23: 1316-1322
  • 62 Yoo SD, Jung SS, Kim HS et al. Efficacy of ultrasonography guided stellate ganglion blockade in the stroke patients with complex regional pain syndrome. Ann Rehabil Med 2012; 36: 633-639
  • 63 Pahapill PA, Zhang W. Restoration of Altered Somatosensory Cortical Representation With Spinal Cord Stimulation Therapy in a Patient With Complex Regional Pain Syndrome: A Magnetoencephalography Case Study. Neuromodulation 2013;
  • 64 Geurts JW, Smits H, Kemler MA et al. Spinal Cord Stimulation for Complex Regional Pain Syndrome Type I: A Prospective Cohort Study With Long-Term Follow-Up. Neuromodulation 2013;
  • 65 Poree L, Krames E, Pope J et al. Spinal cord stimulation as treatment for complex regional pain syndrome should be considered earlier than last resort therapy. Neuromodulation 2013; 16: 125-141
  • 66 Krans-Schreuder HK, Bodde MI, Schrier E et al. Amputation for long-standing, therapy-resistant type-I complex regional pain syndrome. J Bone Joint Surg Am 2012; 94: 2263-2268
  • 67 Moseley GL. Graded motor imagery is effective for long-standing complex regional pain syndrome: a randomised controlled trial. Pain 2004; 108: 192-198
  • 68 Moseley GL. Graded motor imagery for pathologic pain: a randomized controlled trial. Neurology 2006; 67: 2129-2134
  • 69 Johnson S, Hall J, Barnett S et al. Using graded motor imagery for complex regional pain syndrome in clinical practice: failure to improve pain. Eur J Pain 2012; 16: 550-561
  • 70 Beerthuizen A, Stronks DL, Van’t Spijker A et al. Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): prospective study on 596 patients with a fracture. Pain 2012; 153: 1187-1192
  • 71 Shibuya N, Humphers JM, Agarwal MR et al. Efficacy and safety of high-dose vitamin C on complex regional pain syndrome in extremity trauma and surgery – systematic review and meta-analysis. J Foot Ankle Surg 2013; 52: 62-66
  • 72 Wertli M, Bachmann LM, Weiner SS et al. Prognostic factors in complex regional pain syndrome 1: a systematic review. J Rehabil Med 2013; 45: 225-231
  • 73 Dumas S, Pichon B, Dapolito AC et al. Work prognosis of complex regional pain syndrome type I: multicenter retrospective study on the determinants and time to return to work. J Occup Environ Med 2011; 53: 1354-1356